We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microfluidic Extraction Uses High-Density Microarray Biochips

By Biotechdaily staff writers
Posted on 12 Jun 2008
A new fluid extraction method forms the foundation of an innovative technology that enables the expanded use of next-generation sequencers in genomic research. Further investigation of the human genome by resequencing will especially benefit from the new method.

Febit (Heidelberg, Germany) announced the receipt of US patent #7320862 on its microfluidic microarray-based method for extraction of DNA and RNA. Febit uses its microfluidic biochip system Geniom for sequence-based selective isolation of nucleic acids from genomic samples. This new approach to high-throughput sequencing essentially relies on high-density microarray biochips with flexible design, a technology established by febit several years ago. The newly patented method is known as hybselect, targeted sequencing or sequence capture. Using this innovative technique, researchers are able to isolate genes or genomic regions of interest from a complex DNA sample before sequencing.

Febit microfluidic biochip systems have been effectively used for several years in DNA analysis and synthesis. The latest patent was granted in the United States; patents in Europe, and other foreign countries will soon follow. Febit currently holds more than 20 patents and patent applications. In addition to bioanalytics, the company's intellectual property range of products predominantly covers the production of synthetic genes on biochips. Using a focused application strategy, febit has been able to secure intellectual property rights on important product components, processes, and evolving technologies.

Febit's integration of DNA synthesis, analysis, and support in experiment design and bioinformatics helps to understand the data and convert it into results. Geniom is a technologic and service platform implemented in basic and applied research by well known institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with a wide spectrum of applications.


Related Links:
febit

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gold Member
Platelet Function Analyzer
PL-12
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
12 Jun 2008  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
12 Jun 2008  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
12 Jun 2008  |   BioResearch